Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Areata (AA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06340360
What this trial is testing

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Who this might be right for
Alopecia Areata
Nektar Therapeutics 94
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Not applicableStudy completedNCT05594316
What this trial is testing

New Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Al-Azhar University 40
Testing effectiveness (Phase 2)Study completedNCT06402630
What this trial is testing

Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)

Who this might be right for
Alopecia Areata
Soterios Ltd 158
Not applicableStudy completedNCT07455708
What this trial is testing

Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata

Who this might be right for
Alopecia Areata(AA)
Benha University 120
Not applicableStudy completedNCT07101471
What this trial is testing

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Who this might be right for
Alopecia Totalis/UniversalisAlopecia Areata(AA)
NanoAlvand 296
Testing effectiveness (Phase 2)Looking for participantsNCT05551793
What this trial is testing

Regeneron AA Multicenter (Dupilumab)

Who this might be right for
Alopecia Areata
Emma Guttman 76
Early research (Phase 1)Study completedNCT05650333
What this trial is testing

Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

Who this might be right for
Alopecia Areata
Pfizer 15
Testing effectiveness (Phase 2)Study completedNCT06786689
What this trial is testing

To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia Areata(AA)
Sheikh Zayed Medical College 60
Large-scale testing (Phase 3)Active Not RecruitingNCT07023302
What this trial is testing

Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Who this might be right for
Alopecia Areata
AbbVie 125
Not applicableAvailableNCT05522556
What this trial is testing

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Who this might be right for
Alopecia Areata
Pfizer
Early research (Phase 1)Looking for participantsNCT07049328
What this trial is testing

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

Who this might be right for
Alopecia Areata(AA)
HCW Biologics 30